Vasopressin receptors

Trends in Endocrinology and Metabolism

Volumn 11, Issue 10, 2000, Pages 406-410

  Birnbaumer, Mariel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ARGIPRESSIN; COMPLEMENTARY DNA; PHOSPHOLIPASE; VASOPRESSIN RECEPTOR; VASOPRESSIN V1 RECEPTOR; VASOPRESSIN V2 RECEPTOR;

BLOOD PRESSURE REGULATION; ENZYME ACTIVATION; HOMEOSTASIS; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HORMONE RELEASE; HUMAN; MOLECULAR INTERACTION; MUTATION; NEPHROGENIC DIABETES INSIPIDUS; PRIORITY JOURNAL; REVIEW;

ANIMALS; HUMANS; INFANT, NEWBORN; RECEPTORS, VASOPRESSIN; SIGNAL TRANSDUCTION;

EID: 0033664793     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(00)00304-0     Document Type: Review

References (44)

1. Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus
2. Cell-specific gene expression in oxytocin and vasopressin magnocellular neurones
3. Biosynthesis of vasopressin
4. Osmoreceptors in the central nervous system
5. The similarity of effects of vasopressin, adenosine 3',5'-monophosphate (cyclic AMP) and theophylline on the toad bladder
6. Role of cyclic AMP in the action of neurohypophyseal hormones on kidney
7. Characterization of purified endosomes containing the antidiuretic hormone-sensitive water channel from rat renal papilla
8. Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct
9. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine
10. Nephrogenic diabetes insipidus
11. Molecular physiology of urinary concentrating mechanism: Regulation of aquaporin water channels by vasopressin
12. Regulation of pituitary vasopressin receptors during chronic stress: Relationship to corticotrophs responsiveness
13. Vasopressin isoreceptors in mammals: Relation to cAMP-dependent and cAMP-independent transduction mechanisms
14. Molecular cloning and expression of a rat V1a arginine vasopressin receptor
15. Mapping peptide-binding domains of the human V1a vasopressin receptor with a photo-activatable linear peptide antagonist
16. Transient phosphorylation of the V1a vasopressin receptor
17. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor
18. Molecular cloning of the receptor for human anti-diuretic hormone
19. Palmitoylation of the V2 vasopressin receptor
20. A serine cluster prevents recycling of V2 vasopressin receptor
21. Ligand-induced cleavage of the V2 vasopressin receptor by a plasma membrane metalloproteinase
22. Vasopressin receptor mutations and nephrogenic diabetes insipidus
23. Molecular characterization of nephrogenic diabetes insipidus
24. A fully active non-glycosylated V2 vasopressin receptor
25. O-glycosylation of the V2 vasopressin receptor
26. The cloned vasopressin V1a receptor stimulates phospholipase A2, phospholipase C, and phospholipase D through activation of receptor-operated calcium channels
27. Dual signaling potential is common among G(s)-coupled receptors and dependent on receptor density
28. Different single receptor domains determine the distinct G protein coupling profiles of members of the vasopressin receptor family
29. Molecular basis of V2 vasopressin receptor/Gs coupling selectivity
30. Nephrogenic diabetes insipidus: A V2 vasopressin receptor unable to stimulate adenylyl cyclase
31. Role of protein kinase C and carboxyl-terminal region in acute desensitization of vasopressin V1a receptor
32. Insights into the function of type 1 angiotensin II receptors provided by gene targeting
33. Desensitization of the human V2 vasopressin receptor. Homologous effects in the absence of heterologous desensitization
34. Phosphorylation and recycling kinetics of G protein coupled receptors
35. Vasopressin V2 receptor binding is down-regulated during renal escape from vasopressin-induced anti-diuresis
36. Vasopressin release, water channels, and vasopressin antagonism in cardiac failure, cirrhosis, and pregnancy
37. Nonpeptide antagonists for vasopressin receptors. Pharmacology of SR121463A, a new potent and highly selective V2 receptor antagonist
38. Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH)
39. Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure
40. Aquaretic effect of a potent, orally active, nonpeptide V2 antagonist in men
41. Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus
42. Molecular biology of diabetes insipidus
43. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implication
44. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants